Raltegravir-13C6 Potassium Salt |
|
| Synonyms: N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide-13C6 Potassium Salt; | |
| Cat. No.: R11572 | CAS No.: 1391053-33-0 /871038-72-1(unlabelled) |
| MDL.: | Formula: C1413C6H20FKN6O5 |
| F.W.488.46 | Purity: 99％ |
| Storage: No Data Available | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 1mg | POA | Enter qty and click checkbox |
| Catalog Number： | R11572 | CAS No.: | 1391053-33-0 /871038-72-1(unlabelled) | |
| MDL: | Formula: | C1413C6H20FKN6O5 | ||
| F.W.: | 488.46 | Purity: | 99％ | |
| Package: | Unit: | mg | ||
| Appearance: | No Data Available | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | No Data Available | Stability: | ||
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Wade, K., et al.: J. Pharmacol. Biomed. Anal., 8, 401 (1990); Hazuda, D., et al.: Science, 287, 646 (2000); Williams, J., et al.: Drug Metab. Dispos., 32, 1201 (2004); Duckett, C., et al.: Xenobiotica, 36, 59 (2006); Miners, J., et al.: Biochem. Pharmacol | |||
| Application: | The labelled analogue of a potent human immunodeficiency virus (HIV) integrase inhibitor. A novel anti-AIDS drug. | |||
| Category: | Inhibitors, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals, | |||